62 related articles for article (PubMed ID: 2089252)
1. Effect of low-dose calcitriol and calcium therapy on bone histomorphometry and urinary calcium excretion in osteopenic women.
Arthur RS; Piraino B; Candib D; Cooperstein L; Chen T; West C; Puschett J
Miner Electrolyte Metab; 1990; 16(6):385-90. PubMed ID: 2089252
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
Benchimol EI; Ward LM; Gallagher JC; Rauch F; Barrowman N; Warren J; Beedle S; Mack DR
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):538-45. PubMed ID: 18030230
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
Need AG; Horowitz M; Philcox JC; Nordin BE
Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
[TBL] [Abstract][Full Text] [Related]
8. The role of vitamin D in the pathogenesis and treatment of osteoporosis.
Gallagher JC
J Rheumatol Suppl; 1996 Aug; 45():15-8. PubMed ID: 8856646
[TBL] [Abstract][Full Text] [Related]
9. [Intensive vitamin D supplementation in the treatment of osteoporosis].
Stefíková K; Chylová K; Krivosíková Z; Spustová V; Dzúrik R
Vnitr Lek; 2004 Apr; 50(4):286-90. PubMed ID: 15214299
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care.
Jekovec-Vrhovsek M; Kocijancic A; Prezelj J
Dev Med Child Neurol; 2000 Jun; 42(6):403-5. PubMed ID: 10875526
[TBL] [Abstract][Full Text] [Related]
11. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
12. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
[TBL] [Abstract][Full Text] [Related]
13. Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats.
Kainer G; Nakano M; Massie FS; Foreman JW; Chan JC
Pediatr Res; 1991 Dec; 30(6):528-33. PubMed ID: 1805148
[TBL] [Abstract][Full Text] [Related]
14. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
15. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
16. Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women.
Gallagher JC; Bishop CW; Knutson JC; Mazess RB; DeLuca HF
J Bone Miner Res; 1994 May; 9(5):607-14. PubMed ID: 8053388
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcitriol on bone loss after cardiac or lung transplantation.
Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
[TBL] [Abstract][Full Text] [Related]
18. Effect of supplemental calcium on serum and urinary calcium in osteoporotic patients.
Licata AA; Jones-Gall D
J Am Coll Nutr; 1992 Apr; 11(2):164-7. PubMed ID: 1578092
[TBL] [Abstract][Full Text] [Related]
19. [Compliance of postmenopausal osteoporotic and osteopenic patients with calcium and vitamin D therapy].
Akkaya N; Akkaya S; Yıldız N; Atalay NS; Sahin F
Eklem Hastalik Cerrahisi; 2010 Dec; 21(3):130-5. PubMed ID: 21067493
[TBL] [Abstract][Full Text] [Related]
20. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol.
Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP
Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
